These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 3056130

  • 1. Emergency thrombolysis in acute myocardial infarction.
    Heras M, Chesebro JH, Gersh BG, Holmes DR, Mock MB, Fuster V.
    Ann Emerg Med; 1988 Nov; 17(11):1168-75. PubMed ID: 3056130
    [Abstract] [Full Text] [Related]

  • 2. Thrombolytic, antiplatelet, and antithrombotic agents.
    Grines CL.
    Am J Cardiol; 1992 Dec 21; 70(21):18I-26I. PubMed ID: 1471601
    [Abstract] [Full Text] [Related]

  • 3. A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial.
    Cannon CP, McCabe CH, Henry TD, Schweiger MJ, Gibson RS, Mueller HS, Becker RC, Kleiman NS, Haugland JM, Anderson JL.
    J Am Coll Cardiol; 1994 Apr 21; 23(5):993-1003. PubMed ID: 8144799
    [Abstract] [Full Text] [Related]

  • 4. Coronary thrombolysis for evolving myocardial infarction.
    Spann JF, Sherry S.
    Drugs; 1984 Nov 21; 28(5):465-83. PubMed ID: 6391890
    [Abstract] [Full Text] [Related]

  • 5. New developments in thrombolytic therapy.
    Collen D, Gold HK.
    Adv Exp Med Biol; 1990 Nov 21; 281():333-54. PubMed ID: 2129372
    [Abstract] [Full Text] [Related]

  • 6. Gender and acute myocardial infarction: is there a different response to thrombolysis?
    Woodfield SL, Lundergan CF, Reiner JS, Thompson MA, Rohrbeck SC, Deychak Y, Smith JO, Burton JR, McCarthy WF, Califf RM, White HD, Weaver WD, Topol EJ, Ross AM.
    J Am Coll Cardiol; 1997 Jan 21; 29(1):35-42. PubMed ID: 8996292
    [Abstract] [Full Text] [Related]

  • 7. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility Trial.
    Ross AM, Coyne KS, Reiner JS, Greenhouse SW, Fink C, Frey A, Moreyra E, Traboulsi M, Racine N, Riba AL, Thompson MA, Rohrbeck S, Lundergan CF.
    J Am Coll Cardiol; 1999 Dec 21; 34(7):1954-62. PubMed ID: 10588209
    [Abstract] [Full Text] [Related]

  • 8. Thrombolysis with recombinant unglycosylated single-chain urokinase-type plasminogen activator (saruplase) in acute myocardial infarction: influence of heparin on early patency rate (LIMITS study). Liquemin in Myocardial Infarction During Thrombolysis With Saruplase.
    Tebbe U, Windeler J, Boesl I, Hoffmann H, Wojcik J, Ashmawy M, Rüdiger Schwarz E, von Loewis P, Rosemeyer P, Hopkins G.
    J Am Coll Cardiol; 1995 Aug 21; 26(2):365-73. PubMed ID: 7608436
    [Abstract] [Full Text] [Related]

  • 9. Efegatran sulfate as an adjunct to streptokinase versus heparin as an adjunct to tissue plasminogen activator in patients with acute myocardial infarction. ESCALAT Investigators.
    Fung AY, Lorch G, Cambier PA, Hansen D, Titus BG, Martin JS, Lee JJ, Every NR, Hallstrom AP, Stock-Novack D, Scherer J, Weaver WD.
    Am Heart J; 1999 Oct 21; 138(4 Pt 1):696-704. PubMed ID: 10502216
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction: results of the HIT-4 trial.
    Neuhaus KL, Molhoek GP, Zeymer U, Tebbe U, Wegscheider K, Schröder R, Camez A, Laarman GJ, Grollier GM, Lok DJ, Kuckuck H, Lazarus P.
    J Am Coll Cardiol; 1999 Oct 21; 34(4):966-73. PubMed ID: 10520777
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy of streptokinase, but not tissue-type plasminogen activator, in achieving 90-minute patency after thrombolysis for acute myocardial infarction decreases with time to treatment. PERM Study Group. Prospective Evaluation of Reperfusion Markers.
    Steg PG, Laperche T, Golmard JL, Juliard JM, Benamer H, Himbert D, Aubry P.
    J Am Coll Cardiol; 1998 Mar 15; 31(4):776-9. PubMed ID: 9525545
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Thrombolytic treatment in acute myocardial infarction.
    Verstraete M.
    Circulation; 1990 Sep 15; 82(3 Suppl):II96-109. PubMed ID: 2118432
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.